{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:25:48Z","timestamp":1793157948861,"version":"4.5.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T00:00:00Z","timestamp":1481760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["IP.2008.31100.001"],"award-info":[{"award-number":["IP.2008.31100.001"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0167951","type":"journal-article","created":{"date-parts":[[2016,12,16]],"date-time":"2016-12-16T19:56:41Z","timestamp":1481918201000},"page":"e0167951","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal"],"prefix":"10.1371","volume":"11","author":[{"given":"Victorine A.","family":"Mensah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aly","family":"Gueye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magatte","family":"Ndiaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick J.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Anagnostou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massamba","family":"Syll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Ndaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Abiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Bliss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules-Fran\u00e7ois","family":"Gomis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Ogwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tandakha","family":"Dieye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola K.","family":"Viebig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Lawrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Nicosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babacar","family":"Faye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumar","family":"Gaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egeruan B.","family":"Imoukhuede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie J.","family":"Ewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Bejon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian V. S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badara","family":"Cisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"MVVC group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,12,15]]},"reference":[{"key":"ref1","article-title":"World Malaria Report 2013","year":"2013"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e12242","DOI":"10.1371\/journal.pone.0012242","article-title":"Continued decline of malaria in The Gambia with implications for elimination","volume":"5","author":"SJ Ceesay","year":"2010","journal-title":"PLoS One"},{"key":"ref3","article-title":"The changing risk of Plasmodium falciparum malaria infection in Africa: 2000\u201310: a spatial and temporal analysis of transmission intensity","author":"AM Noor","year":"2014","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0140-6736(10)61551-6","article-title":"Malaria elimination: worthy, challenging, and just possible","volume":"376","author":"P Das","year":"2010","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/S0140-6736(10)61494-8","article-title":"Eliminating malaria\u2014all of them","volume":"376","author":"JK Baird","year":"2010","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa1102287","article-title":"First results of phase 3 trial of RTS,S\/AS01 malaria vaccine in African children","volume":"365","author":"ST Agnandji","year":"2011","journal-title":"The New England journal of medicine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa0807381","article-title":"Efficacy of RTS,S\/AS01E vaccine against malaria in children 5 to 17 months of age","volume":"359","author":"P Bejon","year":"2008","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e14090","DOI":"10.1371\/journal.pone.0014090","article-title":"Safety of the malaria vaccine candidate, RTS,S\/AS01E in 5 to 17 month old Kenyan and Tanzanian Children","volume":"5","author":"J Lusingu","year":"2010","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1473-3099(10)70262-0","article-title":"Efficacy of RTS,S\/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5\u201317 months in Kenya and Tanzania: a randomised controlled trial","volume":"11","author":"A Olotu","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref10","article-title":"A Phase 3 Trial of RTS,S\/AS01 Malaria Vaccine in African Infants","year":"2012","journal-title":"The New England journal of medicine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"d7728","DOI":"10.1136\/bmj.d7728","article-title":"What is the efficacy of the RTS,S malaria vaccine?","volume":"343","author":"CJ Duncan","year":"2011","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/mt.2012.223","article-title":"ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans","volume":"20","author":"SH Sheehy","year":"2012","journal-title":"Mol Ther"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e57726","DOI":"10.1371\/journal.pone.0057726","article-title":"Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults","volume":"8","author":"C Ogwang","year":"2013","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/infdis\/jiu579","article-title":"Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals","volume":"211","author":"SH Hodgson","year":"2015","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1038\/ncomms3836","article-title":"Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation","volume":"4","author":"KJ Ewer","year":"2013","journal-title":"Nature communications"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1038\/mt.2014.109","article-title":"Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations","volume":"22","author":"D Kimani","year":"2014","journal-title":"Mol Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4269\/ajtmh.2007.76.486","article-title":"Low-level malaria infections detected by a sensitive polymerase chain reaction assay and use of this technique in the evaluation of malaria vaccines in an endemic area","volume":"76","author":"EB Imoukhuede","year":"2007","journal-title":"The American journal of tropical medicine and hygiene"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"286re285","DOI":"10.1126\/scitranslmed.aaa2373","article-title":"Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults","volume":"7","author":"C Ogwang","year":"2015","journal-title":"Sci Transl Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1475-2875-8-138","article-title":"Highly focused anopheline breeding sites and malaria transmission in Dakar","volume":"8","author":"V Machault","year":"2009","journal-title":"Malar J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/infdis\/jir850","article-title":"Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector","volume":"205","author":"GA O'Hara","year":"2012","journal-title":"The Journal of infectious diseases"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4269\/ajtmh.2005.73.191","article-title":"Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials","volume":"73","author":"L Andrews","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"ref23","first-page":"479","article-title":"Malaria morbidity and therapeutic efficacy of antimalarials. Study conducted in the Dakar region","volume":"53","author":"O Gaye","year":"1993","journal-title":"Med Trop (Mars)"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1038\/mt.2011.176","article-title":"Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors","volume":"19","author":"SH Sheehy","year":"2011","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1128\/CVI.00723-13","article-title":"Assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors","volume":"21","author":"I Nebie","year":"2014","journal-title":"Clinical and vaccine immunology: CVI"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e55571","DOI":"10.1371\/journal.pone.0055571","article-title":"DNA prime\/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity","volume":"8","author":"I Chuang","year":"2013","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.vaccine.2004.08.050","article-title":"Biodistribution and persistence of an MVA-vectored candidate HIV vaccine in SIV-infected rhesus macaques and SCID mice","volume":"23","author":"T Hanke","year":"2005","journal-title":"Vaccine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.virol.2005.10.042","article-title":"Chimpanzee adenovirus vaccine protects against Zaire Ebola virus","volume":"346","author":"GP Kobinger","year":"2006","journal-title":"Virology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/infdis\/124.2.155","article-title":"Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7","volume":"124","author":"FH Top Jr.","year":"1971","journal-title":"J Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1128\/JVI.76.6.2667-2675.2002","article-title":"Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product","volume":"76","author":"Z Xiang","year":"2002","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"11820","DOI":"10.1038\/srep11820","article-title":"Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates","volume":"5","author":"RJ Longley","year":"2015","journal-title":"Sci Rep"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/infdis\/jiw244","article-title":"Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S\/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP","volume":"214","author":"T Rampling","year":"2016","journal-title":"J Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0167951","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T12:35:28Z","timestamp":1568637328000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0167951"}},"subtitle":[],"editor":[{"given":"Thomas L.","family":"Richie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,15]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0167951","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,15]]}}}